As Chief Investment Officer, Justin Kelly ensures the Winslow Capital growth equity process is fully executed by all Portfolio Managers and Analysts. Further, he sets the macroeconomic framework and investment roadmaps for all of Winslow Capital’s products. On the U.S. Large Cap Growth Strategies, he is responsible for portfolio construction and operates as a Portfolio Manager. Justin is a member of Winslow Capital’s Executive Committee and Management Committee. Justin joined Winslow Capital in 1999 as Managing Director responsible for research and portfolio management. Prior to that, he was co-head of the technology research team at Investment Advisers, Inc. in Minneapolis. He also served as an Investment Banker in New York City for Prudential Securities and Salomon Brothers.

Pat Burton is a Portfolio Manager for the suite of U.S. Large Cap Growth Strategies with responsibilities in portfolio construction and stock selection. He also serves as a senior Information Technology sector specialist and leverages his expertise in analyzing both potential technology investments and trends within the ever-changing technology landscape. Pat is a member of Winslow Capital’s Executive Committee and Management Committee. Pat joined Winslow Capital in 2010 as a Managing Director/ Analyst responsible for the Technology sector. Prior to that, he was Senior Equity Research Analyst for Thrivent Asset Management in Minneapolis. He also served as a Managing Director for Citigroup Investments.

Peter Dlugosch is a Portfolio Manager for the U.S. Large Cap Growth Strategy. His primary role is risk management. He leverages his extensive quantitative, trading and analytical experience to help manage portfolio and stock risk and assist with new idea generation. He works closely with the Team to optimize position sizes through his holistic understanding of the entire portfolio in context of the overall market and is actively involved in position sizing, macro updates, new idea generation and risk management. Peter joined Winslow Capital in 2013 as an equity trader. Prior to that he was an executive director, Institutional Equity Sales & Trading at UBS Investment Bank in Boston.

Steve Hamill is a Portfolio Manager for the suite of U.S. Large Cap Growth Strategies, with responsibilities in portfolio construction and stock selection. He also serves as a senior Healthcare sector specialist analyzing new medical discoveries, consumption trends and political shifts to help identify investment opportunities. Further, Steve analyzes U.S. government policy changes that may impact the broader economy or markets for the entire Investment Team. Steve joined Winslow Capital in 2006 as Managing Director/ Analyst responsible for the Healthcare sector. Prior to that, he was a Senior Analyst at Piper Jaffray and RBC Capital Markets providing research on the medical device industry. He also served as a Manager at Arthur Andersen.